Asthma  >>  Budenofalk granules (budesonide gastro-resistant granules)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Budenofalk granules (budesonide gastro-resistant granules) / Dr Falk
NCT02991859 / 2016-003002-14: Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Completed
2a
56
Europe
Fluticasone furoate (FF) Dry Powder Inhaler, Fluticasone propionate (FP) Dry Powder Inhaler, Budesonide (BUD) Turbuhaler, Placebo (ELLIPTA or DISKUS)
GlaxoSmithKline
Asthma
12/18
12/18

Download Options